Market Cap : 8.29 B | Enterprise Value : 8.12 B | P/E (TTM) : | P/B : 48.76 |
---|
NAS:BBIO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:BBIO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
BridgeBio Pharma's Accounts Payable for the three months ended in Sep. 2020 was $9.84 Mil. BridgeBio Pharma's Cost of Goods Sold for the three months ended in Sep. 2020 was $0.00 Mil.
During the past 3 years, BridgeBio Pharma's highest Days Payable was 1436.49. The lowest was 1292.39. And the median was 1292.39.
BridgeBio Pharma's Days Payable declined from Sep. 2019 (374.86) to Sep. 2020 (0.00). It may suggest that BridgeBio Pharma accelerated paying its suppliers.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
* The bar in red indicates where BridgeBio Pharma's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
BridgeBio Pharma's Days Payable for the fiscal year that ended in Dec. 2019 is calculated as
Days Payable | = | Accounts Payable | / | Cost of Goods Sold | * | Days in Period |
= | 8.852 | / | 2.5 | * | 365 | |
= | 1,292.39 |
BridgeBio Pharma's Days Payable for the quarter that ended in Sep. 2020 is calculated as:
Days Payable | = | Accounts Payable | / | Cost of Goods Sold | * | Days in Period |
= | 9.839 | / | 0 | * | 365 / 4 | |
= |
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
No Headline